Day One Biopharmaceuticals Inc (DAWN)
R&D Expense Growth
30.33%
Quarterly · Period ending:
DAWN R&D Expense Growth
Latest reported30.33%period ending
Latest reported30.33%period ending
DAWN Quarterly R&D Growth (QoQ) (0.00% → 30.33%)
Latest values, visible window
High-resolution chart · PNG
DAWN r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 30.3288% | |
| -13.0847% | |
| -8.7584% | |
| -35.9154% | |
| 84.1999% | |
| -63.5605% | |
| 129.0624% | |
| 7.6631% | |
| 12.6195% | |
| 3.0483% | |
| 15.6461% | |
| 6.9485% | |
| 18.0849% | |
| -2.3271% | |
| 50.3699% | |
| 34.087% | |
| 13.6054% | |
| -0.6556% | |
| -21.5168% | |
| 203.2893% | |
| 64.1703% | |
| 76.5484% | |
| 49.5317% | |
| 0% |